Sarcopenia Market to Grow Positively at a Paltry CAGR During the Study Period (2020-2034) | Biophytis, Rejuvenate Biomed, Lipocine Inc, and others

DelveInsight's "Sarcopenia - Market Insight, Epidemiology and Market Forecast - 2034" report provides current treatment practices, emerging drugs, Sarcopenia market share of the individual therapies, current and forecasted Sarcopenia market size from 2020 to 2034 segmented by seven major markets. The report also offers current Sarcopenia therapy algorithms, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Sarcopenia market.
Download our sample report @ https://www.delveinsight.com/report-store/sarcopenia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Sarcopenia Overview
Sarcopenia is an age-related condition characterized by the progressive loss of skeletal muscle mass, strength, and function. While a decline in muscle mass and quality is a natural part of aging, sarcopenia represents an accelerated and pathological manifestation of this phenomenon. Factors contributing to its onset include hormonal changes, reduced physical activity, insufficient nutrition, and chronic illnesses. Sarcopenia can lead to decreased mobility, increased susceptibility to falls and fractures, and an overall diminished quality of life.

Sarcopenia Diagnosis

Diagnosing sarcopenia involves a comprehensive assessment that includes clinical evaluation, muscle mass measurement, and functional testing. There is no single definitive diagnostic criterion, but common methods include:

- Dual-energy X-ray Absorptiometry (DXA): To quantify muscle mass.
- Bioelectrical Impedance Analysis (BIA): To assess body composition.
- Magnetic Resonance Imaging (MRI): To measure muscle mass and quality.

Additionally, physical performance tests such as gait speed, chair stands, and grip strength are often employed to evaluate functional capacity. The diagnosis takes into account an individual's age, gender, and overall health, comparing muscle mass and function to established reference values. Integrating these diverse measures provides a holistic understanding of the presence and severity of sarcopenia, guiding appropriate interventions and management strategies.

Sarcopenia Treatment

The treatment of sarcopenia typically involves a multifaceted approach addressing both lifestyle and medical factors. Key components include:

- Resistance Training Exercises: Focusing on progressive strength training to improve muscle mass and function.
- Adequate Protein Intake: Along with balanced nutrition, to support muscle health.
- Vitamin D and Calcium Supplementation: Especially if deficiencies are identified.

In some cases, hormone replacement therapies and medications targeting muscle function and overall health may be considered. A personalized treatment plan, tailored to the individual's specific needs and underlying health conditions, is essential for effectively managing sarcopenia and promoting functional independence in older adults. Regular monitoring and adjustments to the treatment plan are often necessary to optimize outcomes.

To know more about sarcopenia, causes, treatment options, visit: https://www.delveinsight.com/report-store/sarcopenia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Key Highlights from the sarcopenia market report:
The Sarcopenia market is projected to witness consistent growth throughout the forecast period (2024-2034). The market size of Sarcopenia in the 7MM is expected to increase, driven by better diagnosis and the launch of emerging therapies.
DelveInsight's analyst projects that among the total diagnosed prevalent cases of Sarcopenia in 7MM approximately 55% of cases were from the US. As per our estimations, in 2022, EU4 and the UK accounted for around 7 million diagnosed prevalent cases of Sarcopenia.
In the 7MM, the market mainly consisted of standard treatments like supportive care (vitamin D, hormone therapies, and other off-label use of drugs) which generated nearly USD 2,731 million in 2022.
The total market size of the Sarcopenia treatment market is anticipated to experience growth during the forecast period due to the emergence of new and effective treatments, namely, Sarconeos (BIO101) and MYMD-1.

Sarcopenia Epidemiological Insights
As per DelveInsight estimates, the total prevalent population of Sarcopenia in the 7MM was found to be 35,800,000 in 2021.
Sarcopenia Treatment Market
Early identification and intervention are crucial for enhancing outcomes in patients with sarcopenia. Regularly screening elderly patients for impairments in physical function and activities of daily living (ADLs) should be a standard part of healthcare visits.

Currently, there are no FDA-approved treatments specifically for sarcopenia. The available management options include nutritional supplementation, resistance training, exercise, and vibrational therapy. However, combined interventions-particularly those integrating comprehensive exercise programs like resistance training with nutritional support-are recommended as they have been shown to be more effective in improving sarcopenia compared to singular treatments.

Promising Therapies in the Sarcopenia Pipeline
Sarconeos (BIO101)
RJx-01
LPCN 1148
And others
Discover more about Sarcopenia therapies in the pipeline @ https://www.delveinsight.com/sample-request/sarcopenia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Leading Companies Working in the Sarcopenia Market
Biophytis
Rejuvenate Biomed
Lipocine Inc
And others
To understand key companies related to the Sarcopenia Market, get a snapshot of the Sarcopenia Regulatory and Patent Analysis @ https://www.delveinsight.com/sample-request/sarcopenia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Scope of the Sarcopenia Market Report
Study Period: 2020-2034
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan]
Key Sarcopenia Companies: Biophytis, Rejuvenate Biomed, Lipocine Inc, and others
Key Sarcopenia Pipeline Therapies: Sarconeos (BIO101), RJx-01, LPCN 1148, and others
Therapeutic Assessment: Sarcopenia current marketed and emerging therapies
Sarcopenia Market Dynamics: Sarcopenia market drivers and barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
Unmet Needs, KOL's views, Analyst's views, Sarcopenia Market Access and Reimbursement
Table of Contents
1. Sarcopenia Market Key Insights
2. Sarcopenia Market Report Introduction
3. Sarcopenia Market Overview at a Glance
4. Sarcopenia Market Executive Summary
5. Disease Background and Overview
6. Sarcopenia Treatment and Management
7. Sarcopenia Epidemiology and Patient Population
8. Patient Journey
9. Sarcopenia Emerging Drugs
10. 7MM Sarcopenia Market Analysis
11. Sarcopenia Market Outlook
12. Potential of Current and Emerging Therapies
13. KOL Views
14. Sarcopenia Market Drivers
15. Sarcopenia Market Barriers
16. Unmet Needs
17. SWOT Analysis
18. Appendix
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Contact Us
Kritika Rehani
info@delveinsight.com
+14699457679

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.